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Abstract   Abdominal aortic aneurysms (AAA or triple A’s) are indolent and 
deadly diseases. Their treatment options involve either an invasive procedure or a 
minimally invasive one. When the minimally invasive procedure, endovascular 
aneurysm repair (EVAR), was introduced, it revolutionized the treatment of 
AAA’s due to advantages such as shortened hospital stays and reduced costs. As 
EVAR requires periodic imaging exams, questions are nowadays being raised re-
garding the procedure’s long-term cost-benefit relation. In order to reduce follow-
up costs, new technological solutions are being pursued, namely EVAR stent-
grafts with sensing capabilities. In this chapter, the suitability of aneurysm sac 
pressure measurement for EVAR surveillance is evaluated using an AAA comput-
er model. In addition the design drivers underlying EVAR stent-grafts are re-
viewed and the development of a new flexible pressure sensor integrated into a 
stent-graft is described. 
Introduction 
In 1948, Albert Einstein was diagnosed with an abdominal aortic aneurysm 
(AAA), i.e., his aorta had a permanent and irreversible localized dilatation having 
at least a 50% increase in diameter compared with the normal one [1], Fig. 1. Like 
him, currently, it is estimated that more than 12 per 100 000 persons-year [2] are 
affected by this relatively indolent but serious condition. 
In an attempt to reinforce the aortic wall and delay the inevitable rupture that 
took Einstein’s life in 1955, Dr. Rudolph Nissen wrapped the visible anterior por-
tion of the aneurysm with polyethene cellophane. Nowadays, two more effective 
treatments are available: open surgery and endovascular aneurysm repair (EVAR). 
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While the first is an invasive procedure, the second is a minimally invasive one 
whose main advantages are decreased blood loss, less early morbidity and mortali-
ty, and shorter hospitalization [2]. 
 
 
Fig. 1. Representation of a normal aorta, (A) a thoracic aortic aneurysm (TAA), and (B) an ab-
dominal aortic aneurysm (AAA). 
When EVAR was introduced, it revolutionized the treatment of aortic aneu-
rysms. However, and in spite of major advances in EVAR techniques, adverse 
reactions still occur [3] and lifelong surveillance is recommended [4]. Due to these 
complications, currently, questions are being raised regarding the follow-up costs 
[5] and alternative approaches, such as a smart stent-graft, are being pursued. 
A stent-graft is an endoprosthesis composed of a metallic scaffold and a poly-
meric covering membrane. Its use and the technological background for the devel-
opment of a new device with sensing capabilities are described in this chapter. 
After describing the current treatment options for aortic aneurysms, stent-graft 
complications are presented as well as their surveillance techniques. Following, 
the devices to measure pressure inside the aneurysm sac are described. The future 
trends for stent-graft’s are also addressed highlighting the features of a smart 
stent-graft. A model of an AAA is presented along with a description of the devel-
opment of a flexible pressure sensor. 
Endovascular Aneurism Repair 
Since the early 1950’s, aneurysms’ standard treatment has consisted of an open 
surgery (done under general anesthesia) and the replacement of the diseased seg-
ment of the aorta by a synthetic prosthetic graft [6], Fig. 2. In spite of its invasive-
ness and the fact of being limited to fit patients, this treatment is still a current 
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practice and less invasive techniques, namely total laparoscopy and assisted lapa-
roscopy, are being studied to minimize its disadvantages [7]. 
 
Fig. 2. Conventional treatment of AAA’s, open surgery to insert a synthetic graft. 
In the beginning of the 1990’s, Volodos (in Ukraine) and Parodi (in Argentina) 
demonstrated that endovascular aneurysm repair (EVAR) was a safe and feasible 
practice [8]. This surgical procedure is done percutaneously and it is minimally 
invasive, Fig. 3. Typically, a small incision is made in each groin to expose the 
femoral arteries. Then, with the aid of catheters and guidewires, a stent-graft is 
guided to the affected artery segment allowing blood to pass without exerting 
pressure in the aneurysm sac and, thus, preventing wall rupture. 
 
Fig. 3. Endovascular aneurysm repair (EVAR), stent-graft deployment sequence. 
The first procedures resulted in several complications, some due to the inherent 
learning process, while others were due to the devices’ inefficiency. With time, 
many of the problems have been solved due to the accumulation of experience and 
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the introduction of better devices but, nevertheless, some problems still occur. 
These complications can be classified as early or late and further detailed as sys-
temic or related with the delivery, deployment, or the device itself [3]. Table 1 
presents some of EVAR’s problems involving stent-grafts. 
Table 1. Complications involving stent-grafts (adapted from [3]). 
Early complications Late complications 
Graft kink 
Endoleaks 
Graft explantation 
Structural failure 
Graft infection 
Graft migration 
Neck dilatation 
Endoleaks 
Structural failure: component separation, fa-
bric tears, hook fractures 
 
The current surveillance protocol involves imaging exams, namely ultrasound 
and computed tomography angiography (CTA), at 1, 6, and 12 months after the 
procedure, and thereafter, on an annual basis [9]. 
Device migration and stent fractures or other indication of device fatigue are 
clear in plain abdominal radiography. Ultrasonography, besides allowing measur-
ing the aneurysm sac, is effective in the detection of endoleaks but, even with en-
hanced sensitivity obtained with the use of contrast agents, requires a skilled tech-
nician to interpret the exams. CTA, MRI (magnetic resonance imaging) and MRA 
(magnetic resonance angiography) are sensitive tools to detect endoleaks but can-
not be repeated often due to radiation and/or the use of nephrotoxic contrast 
agents. Furthermore, these exams are considered time consuming and expensive. 
Measurement of Aneurism Sac Pressure 
None of the medical imaging exams presently used provides measures of the pres-
sure inside the aneurysm sac. This information is important because can be evi-
dence of low-flow endoleaks or endotension [10]. 
Published data describe the use of catheters to measure pressure in the residual 
aneurysm sac [11]. However, although these methods provide precise measure-
ments [4], they are invasive and bear multiple risks. 
An alternative method for the measurement of the aneurysm sac’s pressure is 
the implant of remote pressure transducers during EVAR. This solution is advan-
tageous since measurements can be done when needed (hourly, weekly, etc.) in 
the patient’s home or office instead of a hospital once or twice a year. Another 
important feature is the possibility to measure both the mean pressure and the pul-
satile pressure without increasing risks for the patients. Following, the three tele-
metric pressure sensors currently available will be addressed. 
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Impressure AAA sac pressure transducer 
In 2003, the Impressure AAA Sac Pressure Transducer or RemonAAA from Israe-
li Remon Medical Technologies was the first permanently implantable, ultra-
sound-activated remote pressure transducer to measure intrasac pressure after 
EVAR [12]. 
The transducer, hand sewn to the outside of a stent-graft, contains a piezoelec-
tric membrane that energizes a capacitor when actuated by ultrasound waves from 
a hand-held probe. Once charged, the aneurysm sac pressure is measured followed 
by the generation of an acoustic signal that is relayed to the hand-held probe. The 
probe then converts the acoustic signal to a pressure waveform that is presented on 
a computer screen. 
In spite of ultrasound being safe and widely used for medical imaging, the 
measurement requires the use of an ultrasonic gel and direct contact between the 
skin and the transducer. Another drawback of this sensor is the impossibility of ul-
trasound to travel through air or bone, which may lead to difficulties communicat-
ing with the aneurysm sac. 
The ImPressure sensor is the smallest (3 mm × 9 mm× 1.5 mm) of the three 
sensors described here, is the least radiopaque but still visible. As the sensor is 
sewn to the stent-graft, the fixation location must be carefully chosen in such a 
way that the sensor will measure the pressure inside the excluded aneurysm sac 
without being pushed against the aneurysm wall. 
In October 2006, Remon Medical Technologies announced the first European 
implant of the sensor. 
EndoSure wireless pressure sensor 
The EndoSure Wireless Pressure Sensor (CardioMems, Inc., USA) is made of two 
coils of copper wire within a fused silica matrix with a pressure sensitive surface. 
Passive telemetry is used for the signal transfer between the external device and 
the implant. Through inductive coupling, changes on the internal LC network (ca-
pacitor plus inductor) resonance frequency are detected on the external coil. The 
resonance frequency is related to the ambient pressure in which the sensor is lo-
cated, and specially-designed software transforms the frequency shift between sys-
tolic and diastolic pressures into a wave form and pressure reading [13]. 
As the measurements are acquired via RF, there is no need for contact with the 
patient’s skin or even the removal of the clothes, potentially allowing daily/weekly 
sampling at home. 
The EndoSure sensor is deployed through its own delivery catheter (diameter 
14 Fr/4.7 mm) during the EVAR procedure and has radiopaque markers to clearly 
define its location within the aneurysm sac. 
The EndoSure sensor is cleared by the FDA for the measuring of intrasac pres-
sure during endovascular abdominal aortic aneurysm repair and during endovascu-
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lar thoracic aneurysm repair but is not yet approved for use in chronic surveil-
lance. 
TPS telemetric pressure sensor 
The TPS Telemetric Pressure Sensor was developed by the Helmholtz-Institute for 
Biomedical Engineering, RWTH Aachen in cooperation with the Institute of Ma-
terials in Electrical Engineering, RWTH Aachen [13-14]. 
The TPS sensor consists of an implantable sensor capsule and an external rea-
dout station. The capsule comprises a capacitive absolute pressure sensor and an 
in-capsule signal-processing microchip including an inductive telemetry unit. The 
measured data is fully preprocessed to a digital data stream in the implant, so that 
errors during the transmission or from interferences between the sensor and the 
external readout station can be minimized. Moreover, the additional integrated 
temperature sensor allows errors caused by temperature variations to be noted and 
numerically corrected. In keeping with the requirements of medical implants, the 
pressure capsule has a two-layer encapsulation: a biocompatible, capsule-shaped 
silicone form and a Parylene-C layer creating an enclosed covering and ensuring 
the required stiffness. 
The TPS sensor has fixation holes in both ends allowing to be sutured to the 
outer wall of stent-graft or be introduced separately. 
This device has only been tested in an in vitro model but the results demon-
strate that this is a promising technology [15]. Nonetheless, further clinical studies 
are required to evaluate the TPS Telemetric Pressure Sensor’s durability and accu-
racy. 
EVAR cost benefit 
Comparing EVAR with conventional surgery, the first is preferable due to the fact 
of being less stressful and reducing significantly systemic complications [16], as 
well as having lower costs of inpatient stay and less or no need for intensive care 
facilities during recovery [6,17]. While a number of early studies appeared to sup-
port this claim, nowadays, data shows otherwise [16]. Shorter stays at intensive 
care units and the hospital, reduced use of blood, fewer laboratory studies and 
fewer resources lead to cost savings, but later, additional costs exist for EVAR due 
to surveillance procedures. 
The durability of open surgery, established with long-term follow-up studies, is 
excellent [16], so good that there is little or no requirement for long-term surveil-
lance. Hayter [17] compared both hospital and follow-up costs of patients who had 
undergone EVAR or open surgery and concluded that EVAR costs were higher. 
One of the justifications presented was the endograft’s high price. 
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When EVAR was introduced, it was thought to be more economical than open 
surgery because the price of the first stent-grafts was lower and the surveillance 
costs were not included in the analysis. Nowadays, EVAR can be considered cost-
effective only for very elderly patients or those with a reduced life expectancy and 
doubtful for young patients, those who would benefit more from the short hospital 
stay and early return to full activity offered by open surgery. 
Considering the longer life expectancies and the rising public expectations for 
quality of life, EVAR is an attractive treatment. However, its cost-benefit relation 
can be jeopardized by the requirement of long-term surveillance. In order to re-
duce and even eliminate these exams, new surveillance technologies are being in-
vestigated and the most promising technique identified thus far is remote pressure 
sensing [9]. 
The authors believe that including sensing capabilities in a stent-graft will ben-
efit EVAR’s future. Yet, that may not be enough. Preliminary results of a recent 
survey regarding the ideal features of a stent-graft show that attention should be 
given to the devices adaptability and delivery profile. 
Future Trends for Stent-grafts 
Innovations on mechanisms for pressure detection within the aneurysm sac are be-
ing developed concurrent with novel architectures and materials for the construc-
tion of the stent-graft. Two original proposals that indicate future alternatives for 
stent-graft design are presented next. 
Origami stent-graft 
In 2006, Kuribayashi [18] described the design, the manufacture and the proper-
ties of an origami stent-graft. The new device received this designation because 
the paper folding patterns used in the Japanese art of origami was employed to 
fold it. 
This prosthesis is made from a sheet that is folded dividing a cylindrical tube 
into a series of identical elements with hill and valley folds. The folding pattern 
used is responsible for the decrease and increase of both the diameter and the 
length when the device is folded and deployed, respectively. In addition, the 
folded configuration of each element makes the stent-graft flexible. 
Unlike other devices, the origami stent-graft is made of a single component. A 
nickel titanium alloy is used that not only is biocompatible, but also has a shape 
memory effect that is used for the deployment of the device. Its main disadvantage 
is the price; the origami stent-graft is made using a foil that requires complex roll-
ing and annealing methods to be produced. 
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Rigberg’s stent-graft 
The major determinant of the stent-graft’s diameter when folded is the graft, not 
the stent itself. Thus, in order to reduce the pre-deployment diameter and the size 
of the delivery components, Rigberg presented in 2009 a feasibility study for a 
novel aortic stent-graft material [19]. In his work, the author proposes the re-
placement of currently used graft materials by a nickel titanium alloy (NiTi) thin-
film. This material presents several advantages, such as biocompatibility, supere-
lastic qualities, shape memory properties, and a tensile strength of greater than 500 
MPa. This last feature is of major importance since it enables the development of 
thinner devices with the same, or even higher, mechanical resistance. Moreover, 
the cost of thin-film NiTi is expected to be similar to the cost of ePTFE. Nonethe-
less, further studies regarding thrombogenicity, resistance to infection, and per-
meability are still required. Some design issues, such as the attachment of the stent 
to the graft or complex shapes, also need to be more deeply studied. 
Smart stent-graft 
A smart stent-graft can be defined as a stent-graft with some in-device mechanism 
to perform a given function with communication capabilities to an external ele-
ment. 
Although there is still no commercial device available, a smart stent-graft could 
be decomposed in three elements: a stent-graft, a sensing element and a display. 
The stent-graft, besides shielding the aneurysm from the blood pressure, has built-
in sensing elements that are able to gather information concerning the patient’s 
health and/or the prosthesis performance. The information gathered is then sent to 
an external element - a display - and can be used to diagnose the patient’s or in the 
comprehension of the aneurysm’s sac behavior after the implementation of the 
stent-graft. 
Like a conventional stent-graft, such a device will be classified as a class III 
medical device and, as such, will have to be biocompatible, biostable, non-toxic, 
non-allergic and non- carcinogenic. Furthermore, it will have to be tolerated by the 
human body without causing a foreign body reaction or an inflammatory reaction. 
Regarding the mechanical requisites, the device should be flexible and tough. 
Its components should also be mechanically durable, as well as excellent corrosion 
resistance. For a successful protection of the blood vessel, the device should have 
a design as less invasive as possible in order to minimize flow resistance and pres-
sure drops. Radial force is another relevant feature, not only for stent-grafts to stay 
open without being crushed with muscular activity, but also to provide a good seal 
and to ensure fixation. 
The deployment of the device is a critical step for the procedure’s success, thus, 
the stent-graft should have a low profile to facilitate the deployment and minimize 
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lesions in the access arteries. At this stage, radiopacity is also crucial to ensure the 
correct positioning of the prosthesis. 
From the commercial point of view, the device must be capable of being ade-
quately sterilized and stored as an "off-the-shelf" product. A broad range of sizes 
is desirable since it allows the treatment of a wider array of aneurysm anatomies. 
One of the key questions in the design of a smart stent-graft regards the instru-
mentation capabilities required. Ideally, the device should be able to detect migra-
tion and leakages and possibly also monitor any device material or structural de-
gradation. Regarding the transmission of the measured data, the device must be 
able to transmit the data without any internal power. Moreover, the data cannot in-
terfere with other implants nor be influenced by other electronic signals. 
To assure patient’s comfort and even reduce costs, the measurement protocol 
should be done during the doctor's appointment or at home and the results trans-
mitted to the doctor’s office. Regardless of where measurements are taken, the 
procedure should be quick, the least invasive as possible and avoid any kind of 
pain or even discomfort. 
For a correct interpretation of the information measured, it is crucial to know 
the location where the data is being gathered. 
Abdominal Aortic Aneurysm Model 
Thus far, to measure the aneurysm sac’s pressure, sensors are placed randomly 
and provide information regarding a single point. This data is insufficient to cha-
racterize the pressure distribution inside the aneurysm sac. Therefore, AAA mod-
els using finite elements can become a means to understand the medical condition 
and predict the optimal location to place the sensors. 
Several studies using AAA models composed of a stent-graft, the aorta and the 
aneurysm sac have been presented in the literature [20-22], but they mainly stu-
died the drag forces on the stent-graft, or the stresses on the vessel that can lead to 
rupture. Even though this information is important to improve existing knowledge 
about aneurysms, it conveys no detail about the pressure distribution, or the influ-
ence of AAA geometry on the aneurysm sac pressure. 
Using computer-aided design (CAD) software, it is possible to implement pa-
rametric models to construct tridimensional (3D) models of the desired AAA in a 
fast and efficient manner, as in Fig. 4. For an accurate representation, the model 
must include the blood flow, the bifurcated stent-graft, the aorta wall motion (in-
cluding the aneurysm wall) and the stagnant blood inside the aneurysm sac (essen-
tial for the pressure simulation inside the sac). 
Due to the pulsatile nature of blood flow, transient simulations are often used to 
model the blood flow. Aneurysms can have several geometries and sizes [20,23], 
but AAAs present most commonly a fusiform geometry. The aorta radius ranges 
from 2 to 2,5 cm and the wall thickness presents typical values around 2 – 2,5 mm 
[20,23]. 
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Fig. 4. 3D models of an AAA. a) mechanical model and b) fluidic model. 
Fig. 5 presents the main parameters of the 3D model implemented by the au-
thors to assess the pressure distribution inside the aneurysm sac. The ANSYS mul-
tiple code coupling (MFX) with Fluid Solid Interface (FSI) coupling between 
ANSYS and CFX was used to solve the model. 
 
Fig. 5. Main modeling parameters of an AAA. 
The blood flow is considered newtonian, laminar and incompressible; the den-
sity is equal to 1.05 g/cm3 and the viscosity is 0.0035 Pa.s. 
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The model uses an aorta radius and aorta wall thicknesses of 2.5 cm and 2.5 
mm respectively, and an aneurysm length of 10.5 cm and main radius of 6.7 cm. 
The diseased AAA wall is modeled as a linear, isotropic, elastic material with a 
density ρ = 1.2 g/cm3, a Young’s Modulus E = 4.6 MPa and a Poisson’s ratio of 
0.49 [20]. 
The healthy part of the aorta (AAA neck) and iliacs are also modeled as a li-
near, isotropic, elastic material with a density ρ = 1.2 g/cm3, a Young’s Modulus E 
= 2 MPa and a Poisson’s ratio of 0.45. 
The stent-graft model presented uses SHELL elements, and is modeled as a li-
near, isotropic material with a Young’s Modulus E = 10 MPa and a Poisson’s ratio 
of 0.3. 
The aneurysm sac, an important part of the model for the pressure analysis, is 
modeled as a stagnant liquid by using FLUID80 element from the ANSYS ele-
ment library. This element allows the simulation of stagnant fluids in containers 
with no flow. Fig. 6 gives an overview of the meshed mechanical model. 
 
Fig. 6. Mechanical model mesh. 
The mechanical domain of the simulation assumes zero displacement at the top 
of the AAA neck and at the bottom of the iliacs, while a time dependent uniform 
velocity is applied at the inlet of the fluidic domain (Fig. 7a) and a time dependent 
normal traction (due to luminal pressure) on the outlet (Fig. 7b). The transient 
analysis is performed during a full cardiac cycle (1.1 s). 
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Fig. 7. Fluidic boundary conditions: a) inlet velocity and b) outlet pressure. 
To validate the FSI solver, simulations using a simpler AAA model without 
stent-graft were performed. The results showed a maximum aorta displacement of 
1.9 mm and a maximum stress (von Mises) around 0.4 MPa, which were in good 
agreement with the data from [20] (using a similar geometry size). 
Simulation results of the pressure distribution within the aneurysm sac at sys-
tolic pressure (t = 0.5 s) using the full AAA model with stent-graft are shown in 
Fig. 8a. The simulation results show some small pressure variations along the 
aneurysm sac, with the minimum pressure occurring close to the stent-graft bifur-
cation. A closer look to the stent-graft displacement at the same simulation time 
(Fig. 8b) suggests that the minimum pressures are related to the maximum stent-
graft displacements. 
a) 
 
b) 
 
 
Fig. 8. Simulation results at systolic pressure (t = 0.5 s). a) aneurysm sac pressure and b) stent-
graft displacement. 
The results from Fig. 8a show that the pressure within the aneurysm sac is al-
most uniform but do not give any information about the aneurysm sac pressure 
variation during a full cardiac cycle. Therefore, if two zones are defined (zone 1 
and 2 in Fig. 8a) the mean pressures within those regions can be computed. The 
mean pressures in the two zones along with the pressure boundary condition at the 
outlet are depicted in Fig. 9. 
13 
 
Fig. 9. Pressures inside aneurysm sac (zone 1 and 2 in Fig. 8a) and pressure boundary condition 
at the outlet. 
These simulation results imply that the pressure variations within the aneurysm 
sac are related to the displacement of the stent-graft caused by the luminal pres-
sure. If this is the case, the placement of one sensor on the region with less struc-
tural stability (higher displacement) might be a good indicator, when compared to 
another sensor placed elsewhere within the aneurysm sac, of the structural integri-
ty of the stent-graft. These results also suggest that the pressure variations inside 
the aneurysm sac are related to the stent-graft material (structural behavior). Re-
sults for the same simulation boundary conditions but using a higher Young’s 
Modulus for the stent-graft material, E = 60 MPa, Fig. 10, confirm the assumption 
that the pressure within the aneurysm sac depends on the structural behavior of the 
stent-graft material. In fact, simulations reveal that a large drop on the pressure 
within the aneurysm (> 10 mmHg) sac occurs when the Young’s Modulus is in-
creased from 10 MPa to 60 MPa. 
 
Fig. 10. Pressures inside aneurysm sac on zone 1 (see Fig. 8a) for different stent-graft material 
properties. 
The abdominal aortic aneurysm CFD (Compute Fluid Dynamics) model with 
FSI is a suitable tool to study pressure changes within the aneurysm and indicates 
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that pressure sensors can be used to detect post-EVAR complications. Pressure 
sensing in the aneurysm sac can be used both for leakage detection and to measure 
systolic and diastole blood pressures. If more than one sensor is used, model re-
sults suggest that the differences in pressure within the aneurysm sac can be an in-
dicator of the stent-graft material integrity. 
Development of a Flexible Pressure Sensor 
A key component for the smart stent-graft is the pressure sensor. The sensing ele-
ment must be flexible to enable its conformability to the stent-graft and thus the 
aorta. Such features allow the attachment of the sensor to the stent-graft and their 
deployment in a single step (as opposed to the requirement of two catheters as in 
the EndoSure device). Furthermore, it enables the placement of more than one 
sensor (a sensor cluster) contributing to a more comprehensive study of post-
EVAR aneurysm evolution that, currently, is not possible. 
Capacitive sensor design 
Research on implantable pressure sensors is very active and has been supported 
and justified by the need of continuous pressure monitoring for patients with con-
gestive heart failure, as an early diagnostic mechanism for some risk patients and 
for post-EVAR surveillance [24-25]. 
Implantable pressure sensors are typically categorized into extra-arterial blood 
pressure devices and intra-arterial blood pressure devices [25]. The firsts are 
placed around the blood vessel and perform an indirect pressure measurement 
through the wall or through the expansion and contraction of the artery. They re-
quire an invasive surgical procedure for their implant while, on the other hand, the 
intra-arterial devices are in contact with the blood stream inside of the blood ves-
sels. 
After stent-graft placement, the aneurysm sac gets depressurized and the pres-
sure drops down to a few mmHg as indicated by the simulations (12-22 mmHg 
according to Fig. 9). Therefore, if one wants to sense the luminal pressure value 
(ranges typically between 50 – 160 mmHg) through the aneurysm sac pressure, 
the sensor must be able to measure pressures between 6-26 mmHg. In addition, it 
needs a high dynamic range in order to detect stent-graft complications (in this 
case the sac gets pressurized and pressure increases to the luminal pressure val-
ues). 
Typical configurations of capacitive pressure sensors use square-plate (diaph-
ragm) electrodes separated by a dielectric (oftentimes of air) at a pressure P0. 
Changes on the outside pressure (Pout) deform the square plate and consequently 
generate a capacitive change. A schematic of a square-plate (side length of 2a) 
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pressure sensor is shown in Fig. 11. The sensor involves two coupled domains, 
mechanical and electrical, that define the sensor behavior.  
 
Fig. 11. Schematic of the pressure square (side length = 2a) sensor a) 3D view and b) section cut 
B-B. 
 
Fig. 12. Cross section of a generic deflectable diaphragm. 
A cross section of the square plate sensor is shown in Fig. 12 (section cut B-B) 
where only the mechanical domain is considered.  The side length is 2a, t is the 
thickness and y0 the deflection. The diaphragm is clamped at the edges. For a 
clamped diaphragm under a uniform load (like pressure), the angle of deflection, 
ϕ, is equal to zero at the center (r = 0) and at the edge (r = a) of the diaphragm. For 
these boundary conditions, the deflection of an isotropic square diaphragm under a 
pressure load can be modeled as [26]: 
(1) 
34
0 0
0 2 4 34.20 1.58(1 )out
y yEtP P
ta tυ
 
− = + 
−  
 
where υ is the Poisson’s ratio, E is the Young’s modulus, and ∆P=P0-Pout is the 
pressure load. 
Equation (1) allows the calculation of the deflection at the center of the diaph-
ragm for a given pressure load but the deflection along the diaphragm is still re-
quired to model the capacitive changes due to gap variation. Due to the complexi-
ty of the mechanical deflection calculation, trial functions that describe the 
deflection of the entire diaphragm are usually used [27]. Fig. 13 shows the norma-
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lized deflection for a square diaphragm of side-length 2a when the following trial 
function for large deflection is used [27]: 
(2) 
0( , ) cos cos2 2
x yy x y y
a a
pi pi      
=       
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Fig. 13. Displacement profile along the square diaphragm using the trial function of equation (2). 
Mechanical deflections caused by pressure changes will originate changes at 
the capacitor (electrostatic domain). A capacitor is an electronic component with 
two electrodes that are separated by a dielectric. For the simple case of a parallel 
plate capacitor, and in the absence of displacements, the model for the capacitor is 
(neglecting fringe fields): 
(3) 0
0
r
wlC
d
ε ε=
 
where ε0 is the permittivity of free space (8.8546x10-12 F/m), εr is the relative 
permittivity, w and l are the width and length of the capacitor electrodes, and d0 is 
the gap between the electrodes. 
Since the capacitive sensor uses diaphragm electrodes with a complex bending 
profile, integration over the effective area of the electrodes is required to compute 
the total capacitance: 
(4) 
0
0 2 ( , )
rC dxdy
d y x y
ε ε
=
+∫ ∫
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where y(x,y) is the distance between electrodes due to the diaphragm bending at 
position x, y. The integration in equation (4) can easily be solved numerically, 
enabling the computation of the capacitance for a given pressure change. 
Fabrication process 
Given the characteristics of the application (the sensor will be attached to the 
stent-graft) the capacitive sensor must be foldable, extremely flexible and charac-
terized by a very small profile. In addition, the technology should be simple and 
biocompatible. Silicon based micro technologies are widely used in implantable 
medical devices [24], but due to the application specifications, there are other 
technologies that can deliver better design approaches and results. 
A suitable candidate is the technology proposed by Sepúlveda [28], in which 
aligned carbon nanotubes (CNTs) are used to implement the conductive elements 
in a flexible substrate of polydimethylsiloxane (PDMS), a transparent, nontoxic 
and biocompatible silicone elastomer. 
The technology process flow enabling the fabrication of a flexible pressure sen-
sor is schematically presented in Fig. 14. Acrylic moulds are produced by CNC 
milling (Fig. 14a) for posterior fabrication of the PDMS membranes. This tech-
nique has low costs and fast production times, but it is associated with poor di-
mensional control (dimensions less than 50 µm are difficult to achieve) and more 
traditional micromachining may achieve the required tolerances. 
 
Fig. 14. Fabrication process flow for the development of a flexible pressure sensor with aligned-
CNT/PDMS nanocomposites. 
The electrical components are based on aligned CNTs, as shown in Fig. 14b. 
Chemical vapor deposition (CVD) is used to grow forests or “carpets” of vertical-
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ly-aligned CNTs [29]. A silicon substrate with patterned Fe/Al2O3 catalyst is 
placed on a horizontal quartz tube furnace at atmospheric pressure at 750 ºC [29] 
for the CNT growth. This method has the advantage of allowing the growth of 
high purity, high yield and vertically aligned CNTs. Next, the CNTs are embedded 
into the polymer matrix (PDMS). This step is schematically represented in Fig. 
14c. The substrate is placed against the moulds, and the PDMS is introduced in the 
cavities through a hole to create an aligned-CNT/PDMS nanocomposite as de-
scribed previously for epoxies using capillarity-assisted wetting [30], followed by 
the curing of the elastomer. 
Three flexible membrane layers are required to fabricate the sensor, with the 
top and bottom layers defining the inductor and the electrodes, and the middle one 
defining the dielectric (air). This configuration requires bonding of PDMS mem-
branes. Eddings [31] tested five different bonding techniques and the highest re-
ported bond strength was obtained for both partial curing and uncured PDMS ad-
hesive techniques. The latter approach is used to build the sensors, Fig. 15. 
 
Fig. 15. Cross section of a CNT/PDMS flexible pressure sensor. 
Material properties and results 
The key step of the fabrication process is the CNT-PDMS impregnation and re-
spective mechanical and electrical properties (that will govern the sensor re-
sponse). Aligned CNTs are oriented in the out-of-plane (or normal to the wafer 
plane) direction such that the polymer nanocomposite can be presumed transversly 
isotropic, i.e., isotropic in the plane of the sensor. Furthermore, the modulus en-
hancement due to CNTs is likely minimal as the long axis of the CNTs are 
oriented perpendicular to the loading direction, such that the PDMS polymer do-
minates the response. Work on nanocomposites has shown significant increase in 
modulus due to aligned CNTs in polymer (PDMS) [32] and epoxy [33] in the 
CNT axis direction, but little reinforcement effect in the transverse direction as 
used here. This result is expected from composite micromechanics analyses and 
experimental results. 
Experimental results using a prototype PDMS/CNT flexible pressure sensor are 
presented in Fig. 16. The tested sensors have a mechanical layer thickness of 670 
µm and a dielectric thickness of 260µm resulting in a total sensor thickness of 
1.6mm (670µm + 260µm + 670µm). The area of the electrodes is 3.4 x 9 mm2 (W 
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x L). Despite the coarse sensor resolution (the geometry was not optimized since 
the devices are at a proof-of-concept stage), capacitive changes were measured 
when the sensor was placed inside a controlled pressure chamber (the dielectric is 
hermetically sealed at ambient pressure). 
a) 
 
b) 
 
Fig. 16. Experimental results of a prototype CNT/PDMS flexible pressure sensor for a smart 
stent-graft. a) Capacitive changes vs. pressure and b) image of the sensor with 10 kPa external 
pressure. 
Conclusions 
Since its introduction, in the beginning of the 90’s, EVAR became a viable alter-
native for the treatment of aneurysms. Despite the benefits of being a minimally 
invasive technique, recent cost-benefit analyses indicate that EVAR becomes 
more expensive on the long-term since it requires surveillance mechanisms to 
detect eventual post-EVAR problems, such as endoleaks and stent-graft migration. 
Alternatives are currently being pursued to minimize the surveillance costs, and 
pressure measurements in the aneurysm sac are an attractive solution. Some stand 
alone pressure sensors are already available but the future will evolve to smart 
stent-grafts, i.e., stent-grafts with embedded pressure sensors for post-EVAR sur-
veillance. 
The use of pressure changes as a surveillance mechanism still requires a better 
understanding from the medical community. Nevertheless, AAA model simulation 
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results validate the use of pressure sensors to detect post-EVAR complications. 
Although more data is required, multiple pressure measurements within the aneu-
rysm sac can also enable the detection of stent-graft structural failure. 
In order to place the sensors in the stent-graft, they must be thin and highly 
flexible. A newly developed technology based on CNTs has proven successful in 
the development of flexible pressure sensors and might enable the next generation 
of smart stent-grafts. 
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